Implementing a podiatry prescribing mentoring program in a public health service: a cost-description study
- PMID: 30008807
- PMCID: PMC6043946
- DOI: 10.1186/s13047-018-0282-1
Implementing a podiatry prescribing mentoring program in a public health service: a cost-description study
Abstract
Background: In the management of diabetes and high-risk patients, timely treatment with scheduled medicines is critical to prevent severe infections and reduce the risk of lower extremity amputation. However, in Australia, few podiatrists have attained endorsement to prescribe. The aims of this study were to identify the costs associated with developing and implementing a podiatry prescribing mentoring program; and to compare the cost of this program against potential healthcare savings produced.
Methods: This was a cost-description analysis, involving the calculation of costs associated with the development and implementation of a mentoring program to train podiatrists to become endorsed prescribers. Costs were calculated using the Ingredients Method and examined from the perspective of a public health service provider, and the individual learner podiatrist. Breakeven analysis compared the cost of training a podiatry prescriber for endorsement against the potential benefit (savings) made by averting complications of an infected foot ulcer. A sensitivity analysis was conducted to allow for uncertainty in the results of an economic evaluation.
Results: Total start-up cost for the podiatry prescriber mentoring program was $13, 251. The total cost to train one learner podiatrist was $30, 087, distributed between the hospital $17, 046 and the individual learner $13, 041. In the setting studied, a podiatry prescriber must avert 0.40 major amputations arising from an infected foot ulcer through prescribing to recover the cost of training. If in-kind training costs are included, total cost increases to $50, 654, and the breakeven point shifts to 0.68 major amputations averted.
Conclusion: The economic benefits (savings) created by an endorsed prescribing podiatrist over their career in a public health service are likely to outweigh the costs to train a podiatrist to attain endorsement. Further research is required to help understand the effectiveness of podiatry prescribing in reducing diabetic foot related complications and the potential economic impact of podiatry prescribers on this health condition.
Keywords: Cost; Endorsement; Podiatry; Prescribing; Scheduled medicines.
Conflict of interest statement
This research was deemed exempt from ethics by the Office for Research at Peninsula Health.Not applicable.The authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
Barriers to and facilitators of endorsement for scheduled medicines in podiatry: a qualitative descriptive study.J Foot Ankle Res. 2021 Mar 10;14(1):16. doi: 10.1186/s13047-021-00457-9. J Foot Ankle Res. 2021. PMID: 33691758 Free PMC article.
-
Australian podiatrists scheduled medicine prescribing practices and barriers and facilitators to endorsement: a cross-sectional survey.J Foot Ankle Res. 2022 Feb 8;15(1):11. doi: 10.1186/s13047-022-00515-w. J Foot Ankle Res. 2022. PMID: 35135610 Free PMC article.
-
A comparative case study of prescribing and non-prescribing physiotherapists and podiatrists.BMC Health Serv Res. 2020 Nov 24;20(1):1074. doi: 10.1186/s12913-020-05918-8. BMC Health Serv Res. 2020. PMID: 33234141 Free PMC article.
-
Enhancing diabetic foot management: Advocating for independent prescribing rights for podiatrists in South Africa.Foot (Edinb). 2024 Sep;60:102126. doi: 10.1016/j.foot.2024.102126. Epub 2024 Aug 22. Foot (Edinb). 2024. PMID: 39178497 Review.
-
A decade of independent prescribing in the UK: a review of progress.J Foot Ankle Res. 2022 May 11;15(1):35. doi: 10.1186/s13047-022-00541-8. J Foot Ankle Res. 2022. PMID: 35546680 Free PMC article. Review.
Cited by
-
Economic evaluation of CPD activities for healthcare professionals: A scoping review.Med Educ. 2022 Oct;56(10):972-982. doi: 10.1111/medu.14813. Epub 2022 Apr 29. Med Educ. 2022. PMID: 35451106 Free PMC article.
-
Barriers to and facilitators of endorsement for scheduled medicines in podiatry: a qualitative descriptive study.J Foot Ankle Res. 2021 Mar 10;14(1):16. doi: 10.1186/s13047-021-00457-9. J Foot Ankle Res. 2021. PMID: 33691758 Free PMC article.
-
Australian podiatrists scheduled medicine prescribing practices and barriers and facilitators to endorsement: a cross-sectional survey.J Foot Ankle Res. 2022 Feb 8;15(1):11. doi: 10.1186/s13047-022-00515-w. J Foot Ankle Res. 2022. PMID: 35135610 Free PMC article.
-
Continuing professional development opportunities for Australian endorsed for scheduled medicines podiatrists-What's out there and is it accessible, relevant, and meaningful? A cross-sectional survey.PLoS One. 2023 Sep 21;18(9):e0289217. doi: 10.1371/journal.pone.0289217. eCollection 2023. PLoS One. 2023. PMID: 37733657 Free PMC article.
References
-
- Nissen L, Kyle G. Non-medical prescribing in Australia. Aust Prescr. 2010;33:166–167. doi: 10.18773/austprescr.2010.075. - DOI
-
- Australian Health Ministers' Advisory Council: Guidance for National Boards: Applications to the Ministerial Council for approval of endorsements in relation to scheduled medicines under section 14 of the National Law. 2016.
-
- Commonwealth of Australia: Portfolio Budget Statements 2010–11 . Ageing Health and Education. Canberra: Commonwealth Copyright Administration; 2010.
-
- Queensland Government: Health practitioner regulation National law act 2009. Queensland; 2009.
-
- Podiatry Board of Australia: Guidelines for endorsement for scheduled medicines. (Agency AHPR ed.; 2011.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources